Over 60 Per Cent of West African Workers Lack Malaria Support

Over 60 per cent of workers in West Africa do not receive any form of malaria support from their employers, according to a new survey by the Corporate Alliance on Malaria in Africa (CAMA).

The findings reveal that 62 per cent of respondents across the region have no access to workplace-based malaria prevention or treatment programmes. This gap leaves a significant portion of the regional workforce vulnerable to a disease that remains a primary driver of absenteeism and reduced economic productivity.

The survey highlights a critical disconnect between the known public health burden of malaria and the corporate health policies adopted by businesses in West Africa. While many firms provide general health insurance through Health Maintenance Organisations (HMOs), specific interventions tailored to malaria prevention are largely absent.

Workplace support typically includes the provision of insecticide-treated nets, the implementation of indoor residual spraying in office environments, and the availability of rapid diagnostic tests (RDTs) for early detection and treatment.

CAMA noted that the lack of targeted support increases the likelihood of prolonged illness among employees. Without early detection and immediate treatment, malaria cases often escalate, leading to longer periods of sick leave and a subsequent drop in organizational output.

The economic implications extend beyond the individual worker. For businesses, the cost of malaria is measured in lost man-hours and the disruption of operational workflows. In regions where malaria is endemic, the disease functions as a hidden tax on corporate efficiency.

Economic Impact of Malaria Related Absenteeism

Malaria continues to be one of the most significant health challenges affecting the World Health Organization’s monitored regions, with Sub-Saharan Africa bearing the highest burden. The resulting absenteeism creates a ripple effect throughout the supply chain, particularly in labour-intensive sectors such as manufacturing, agriculture, and construction.

The cost of untreated or late-treated malaria includes not only the direct cost of medical care but also the indirect cost of reduced worker performance. Workers returning from malaria-related illness often experience a period of reduced cognitive and physical capacity, affecting overall quality of work.

CAMA argues that the private sector has a commercial incentive to integrate malaria control into their operational strategies. Investing in preventative measures is significantly cheaper than absorbing the costs of productivity loss and high employee turnover associated with chronic health struggles.

The alliance encourages companies to move beyond basic insurance and adopt a proactive “Malaria-Free Workplace” framework. This includes educating staff on prevention and ensuring that treatment is accessible and affordable for all levels of employees, including contract staff and day labourers.

The survey suggests that companies that do provide support see a measurable improvement in attendance rates and employee morale. However, these firms remain the minority in the West African corporate landscape.

Integrating malaria support into corporate social responsibility (CSR) and occupational health and safety (OHS) policies is seen as a necessary step for businesses aiming for sustainable growth. The African Union’s health goals emphasize the need for multisectoral partnerships to eliminate the disease, placing the private sector in a key position to drive change.

Current trends in regional labour markets show a growing demand for comprehensive employee wellness packages. Businesses that fail to address endemic health risks like malaria may find it harder to attract and retain top talent compared to competitors who prioritize worker health.

CAMA intends to engage more closely with chambers of commerce and industry leaders to develop a set of standardised workplace malaria guidelines. The goal is to shift the perception of malaria prevention from a charitable act to a strategic business investment.

The next phase of the initiative involves partnering with health providers to create low-cost, high-impact malaria screening packages for small and medium-sized enterprises (SMEs), which often lack the budget for comprehensive corporate health schemes.

Explore more Business stories and analysis from Business Elites Africa.

Leave a Reply